OREGON CITY, Ore. -- The Hepatitis C Caring Ambassadors Program (HCCAP) proudly announces the Internet release of the newly updated 3rd edition of Hepatitis C Choices: Distinctive Viewpoints on Choices for Your Hepatitis C Journey. The book is authored by a team of 20 leading medical experts and patient advocates. Hepatitis C Choices presents an objective review of conventional and alternative treatment options for the more than four million Americans currently infected with the hepatitis C virus (HCV). It is the only book of its kind currently available.
Hepatitis C Choices thoroughly reviews conventional (Western) treatment along with naturopathic, Ayurvedic, homeopathic, and traditional Chinese medicine management approaches. Other important topics such as disease progression, nutrition, laboratory testing, and health care consumer information are also included. In addition to extensive updates, the 3rd edition of Hepatitis C Choices has two new chapters on integrative medicine and immunology. According to Dr. Robert Gish, Medical Director of the Liver Transplant Program at California Pacific Medical Center in San Francisco, "Hepatitis C Choices provides not only choices on treatment for hepatitis C, it delivers a detailed overview of background information for patients seeking answers to key facts on why their specific treatment pathway is correct for them."
The 3rd edition of Hepatitis C Choices is available for free download at the Hepatitis C Caring Ambassadors Program Internet site at www.hepcchallenge.org.
Source: The Hepatitis C Caring Ambassadors Program
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Flawed From the Start: Why Many IFUs for Surgical Instruments Fail in Real-World Sterile Processing
July 23rd 2025At the 2025 HSPA Annual Conference & Expo, Cori L. Ofstead, MSPH, highlighted critical flaws in manufacturers’ instructions for use (IFUs) for orthopedic and neurosurgical instruments. From contradictory directions to unrealistic cleaning expectations, these IFUs often fail under real-world conditions, jeopardizing both patient safety and sterile processing workflows.
US Withdrawal From UNESCO Signals a Dangerous Step Back for Global Science
July 22nd 2025In a decision heavy with consequence and light on foresight, the US has once again chosen to walk away from UNESCO, leaving behind not just a seat at the table, but a legacy of global scientific leadership that now lies in question.
Pathogen Pulse: Facilities Need the SPD, Yersinia Enterocolitica Outbreak, and More
July 22nd 2025From unsterilized surgical tools in Colorado to a years-long methicillin-resistant Staphylococcus aureus (MRSA) outbreak in Virginia and a surging measles crisis in Canada, recent headlines reveal the fragile front lines of infection prevention and the high stakes when systems fail.
Telemedicine's Transformative Role in PPE Distribution and Sterile Equipment Management
July 22nd 2025In an era defined by digital transformation and post-pandemic urgency, telemedicine has evolved beyond virtual visits to become a vital infrastructure for delivering personal protective equipment (PPE) and managing sterile supplies. By enabling real-time forecasting, remote quality control, and equitable distribution, telemedicine is revolutionizing how health care systems protect both patients and providers.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.